|
Market Closed -
Nasdaq
02:30:00 10/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0400 USD | -27.14% |
|
-64.29% | -99.46% |
| 06/11 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) dropped from S&P TMI Index | CI |
| 04/11 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) dropped from Russell Microcap Growth Benchmark Index | CI |
| Market Cap | 9L 8L 7L 7L 12.82L 8.5Cr 13.14L 89.14L 35.53L 4.55Cr 34.05L 33.32L 14Cr | P/E 2026 * |
-0.01x | P/E 2027 * | -0.02x |
|---|---|---|---|---|---|
| Enterprise Value | 9L 8L 7L 7L 12.82L 8.5Cr 13.14L 89.14L 35.53L 4.55Cr 34.05L 33.32L 14Cr | EV / Sales 2026 * |
0.01x | EV / Sales 2027 * | 0.01x |
| Free-Float |
95.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KPTI | Delayed | |
CBOE
| KPTI | Real-time | |
|
Tradegate
| 25K0 | Real-time | |
|
Boerse Muenchen
| 25K0 | Real-time | |
|
Deutsche Boerse AG
| 25K0 | Delayed | |
|
Börse Stuttgart
| 25K0 | Delayed |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | -27.14% | ||
| 1 week | -64.29% | ||
| Current month | -93.96% | ||
| 1 month | -93.39% | ||
| 3 months | -98.11% | ||
| 6 months | -99.54% | ||
| Current year | -99.46% |
| 1 week | 0.04 |  | 0.13 |
| 1 month | 0.04 | | 0.99 |
| Current year | 0.04 | | 10.99 |
| 1 year | 0.04 | | 10.99 |
| 3 years | 0.04 | | 29.25 |
| 5 years | 0.04 | | 220.95 |
| 10 years | 0.04 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 03/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 03/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 63 | 01/01/2013 |
| Director/Board Member | 61 | 01/04/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 03/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/10/26 | Sell | Controller/Auditor | -4,788 | 0.0211% | ||
| 01/10/26 | Sell | Controller/Auditor | -378 | 0.0017% | ||
| 01/09/26 | Sell | Controller/Auditor | -19 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -27.14% | -64.29% | -99.22% | -99.62% | 12.45L | |
| +4.28% | +0.07% | +52.75% | +138.78% | 1,20600Cr | |
| +2.13% | +4.27% | +51.21% | +91.36% | 66TCr | |
| +0.68% | +1.54% | +33.83% | +112.47% | 51TCr | |
| +2.77% | +0.98% | +49.44% | +68.46% | 38TCr | |
| +1.38% | +0.27% | +72.42% | +45.30% | 36TCr | |
| +0.29% | +1.48% | +30.84% | +58.32% | 31TCr | |
| +0.98% | +1.49% | +9.04% | +34.78% | 29TCr | |
| +1.04% | -0.05% | +45.29% | +76.18% | 25TCr | |
| +1.46% | -0.59% | +42.48% | +125.82% | 21TCr | |
| Average | -1.18% | -6.11% | +28.81% | +65.19% | 42TCr | |
| Weighted average by Cap. | +2.30% | +0.65% | +45.99% | +96.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14Cr 12Cr 11Cr 10Cr 19Cr 1.27TCr 20Cr 133.26Cr 53Cr 680.59Cr 51Cr 50Cr 2.14TCr | 17Cr 15Cr 14Cr 13Cr 25Cr 1.63TCr 25Cr 170.54Cr 68Cr 871Cr 65Cr 64Cr 2.74TCr |
| Net income | -16Cr -14Cr -13Cr -12Cr -23Cr -1.5TCr -23Cr -157.37Cr -63Cr -803.75Cr -60Cr -59Cr -2.53TCr | -11Cr -10Cr -9.44Cr -8.56Cr -16Cr -1.08TCr -17Cr -112.89Cr -45Cr -576.56Cr -43Cr -42Cr -1.82TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | $0.0400 | -27.14% | 2,37,22,490 |
| 06/26/06 | $0.0549 | -8.65% | 10,45,37,597 |
| 05/26/05 | $0.0601 | -17.56% | 1,88,47,981 |
| 04/26/04 | $0.0729 | -17.44% | 4,09,15,198 |
| 03/26/03 | $0.0883 | -21.16% | 1,68,68,112 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
